LINC01619
Uncharacterized protein encoded by LINC01619
Also known as: CL079_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for LINC01619 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
115 residues, UniProt reviewed canonical sequence.
>G3V211|LINC01619
1 MNVCCSSHPV NEKVWKPSSR KWSSKVWSMD EFDLQTACYW FMTRCQKEAG KFGTHRGKPM
61 CFVRSLLRVQ LLPRTFPANS FVISFFPSLI YPLQVYQLHF ESSDKQRAMQ FVTEGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LINC01619 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.49
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LINC01619 as an antibody target. Whether an autoantibody or antibody against LINC01619 could matter depends on whether native LINC01619 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LINC01619 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LINC01619 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...